SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-030329
Filing Date
2024-02-09
Accepted
2024-02-09 17:21:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d748203ds3.htm S-3 193084
2 EX-5.1 d748203dex51.htm EX-5.1 10071
3 EX-23.1 d748203dex231.htm EX-23.1 2028
4 EX-FILING FEES d748203dexfilingfees.htm EX-FILING FEES 48241
5 GRAPHIC g748203g0209131622624.jpg GRAPHIC 2534
6 GRAPHIC g748203g82e20.jpg GRAPHIC 35325
  Complete submission text file 0001193125-24-030329.txt   307001
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276995 | Film No.: 24616231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)